Position in NVO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$3,170,511
+$1,547,154 QoQ
Shares Held
66,135
+49.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#291
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $46,810,911 across 13 Drug Manufacturers - General names. NVO ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,775 | $12,923,859 | |
| 2 | ABBV |
AbbVie Inc.
|
40,584 | $10,212,557 | |
| 3 | JNJ |
Johnson & Johnson
|
22,980 | $5,836,230 | |
| 4 | AMGN |
Amgen Inc
|
14,031 | $5,080,905 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
66,135 | $3,170,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,666 | $2,655,581 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
35,462 | $2,043,320 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,955 | $1,636,734 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,170,511 | 66,135 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,623,357 | 44,173 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,932,829 | 37,988 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,994,684 | 53,968 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,616,717 | 52,401 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $3,389,366 | 48,810 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,034,304 | 12,024 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,420,454 | 20,328 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,587,697 | 11,123 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,379,272 | 10,742 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $611,079 | 5,907 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $640,126 | 7,039 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $599,256 | 3,703 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $575,450 | 3,616 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $496,021 | 3,665 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $366,738 | 3,681 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $399,922 | 3,589 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $397,781 | 3,582 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $394,240 | 3,520 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $339,395 | 3,535 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $295,205 | 3,524 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $241,633 | 3,584 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $243,916 | 3,492 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $256,335 | 3,692 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $245,288 | 3,746 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $222,800 | 3,701 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||